DIABETIC MACULAR EDEMA

This study tests an experimental drug called SNP318 in 60 people with diabetic macular edema (DME), a condition that causes vision loss due to swelling in the retina. The goal is to see if the drug is safe and can improve vision or reduce swelling compared to a placebo. Participa…

This early-stage study tests a nose spray form of octreotide for diabetic macular edema, a condition that causes vision loss. It includes 60 adults who haven't responded well to current treatments. The goal is to see if the spray is safe and can reduce retinal swelling and improv…

This study tests whether taking a probiotic (Lactobacillus plantarum 299v) twice daily for four months can reduce retinal swelling and improve vision in people with diabetic macular edema. Thirty-six adults with the condition will take the supplement, and their results will be co…

This study tests an oral medication, CU06-1004, taken once daily for 24 weeks in about 156 people with diabetic macular edema (DME), a condition that causes vision loss due to swelling in the center of the retina. Participants are randomly assigned to receive a low dose, a high d…

This study tests whether a new prefilled syringe (SCD411) is easy and safe for eye doctors to use when treating wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic retinopathy. About 33 doctors will use the syringe and researchers wil…

This study tests two different laser settings (5% vs 15% duty cycle) to treat diabetic macular edema, a swelling in the back of the eye caused by diabetes. About 50 adults with mild vision loss and moderate swelling will receive one of the two laser treatments. The main goal is t…

This study will use a special eye scan called OCT to look for early signs of retinal damage in people with diabetes who have no vision problems. Researchers will compare the eye scans of 112 diabetic participants with healthy controls to see if OCT can detect changes before sympt…

This early-stage study tests a new medicine, BI 3812465, in adults with diabetic macular edema (swelling in the center of the eye). The main goal is to see if different doses are safe and tolerable. Participants receive three injections into the eye over several months and are mo…

This study tests if using a cotton-tipped applicator to hold the eyelid open during eye injections causes less pain and is faster than the standard metal speculum. About 120 people with certain eye conditions will take part. The goal is to see which method patients prefer and if …

This study will test a new, non-invasive eye scanner (wide field OCTA) in 200 adults with various eye diseases like age-related macular degeneration, diabetic retinopathy, and uveitis. The goal is to see if this device provides better images of blood vessels in the back and front…

This study tests whether a personalized care approach helps patients with chronic macular diseases (like wet age-related macular degeneration and diabetic macular edema) attend their regular eye injection appointments. Many patients skip these vital treatments, risking vision los…